
Stephen Gucker
Examiner (ID: 445)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1647, 1812, 1818, 1646, 1645 |
| Total Applications | 799 |
| Issued Applications | 370 |
| Pending Applications | 114 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4302045
[patent_doc_number] => 06326154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Ligand-mediated immunofunctional hormone binding protein assay method'
[patent_app_type] => 1
[patent_app_number] => 8/441553
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 21666
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 279
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326154.pdf
[firstpage_image] =>[orig_patent_app_number] => 441553
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441553 | Ligand-mediated immunofunctional hormone binding protein assay method | May 14, 1995 | Issued |
Array
(
[id] => 3939340
[patent_doc_number] => 05981480
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Pantropic neurotrophic factors'
[patent_app_type] => 1
[patent_app_number] => 8/441513
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 74
[patent_no_of_words] => 23132
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981480.pdf
[firstpage_image] =>[orig_patent_app_number] => 441513
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441513 | Pantropic neurotrophic factors | May 14, 1995 | Issued |
Array
(
[id] => 3620242
[patent_doc_number] => 05593844
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Ligand-mediated immunofunctional hormone binding protein assay method'
[patent_app_type] => 1
[patent_app_number] => 8/441357
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 21546
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593844.pdf
[firstpage_image] =>[orig_patent_app_number] => 441357
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441357 | Ligand-mediated immunofunctional hormone binding protein assay method | May 14, 1995 | Issued |
Array
(
[id] => 3879827
[patent_doc_number] => 05728803
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Pantropic neurotrophic factors'
[patent_app_type] => 1
[patent_app_number] => 8/440049
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 73
[patent_no_of_words] => 21859
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728803.pdf
[firstpage_image] =>[orig_patent_app_number] => 440049
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/440049 | Pantropic neurotrophic factors | May 11, 1995 | Issued |
| 08/437612 | DNA ENCODING TURKEY HYPOTHALAMIC VASOACTIVE INTESTINAL PIPTIDE | May 8, 1995 | Abandoned |
Array
(
[id] => 3661570
[patent_doc_number] => 05624899
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Method for using Htk ligand'
[patent_app_type] => 1
[patent_app_number] => 8/436044
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 28027
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624899.pdf
[firstpage_image] =>[orig_patent_app_number] => 436044
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436044 | Method for using Htk ligand | May 4, 1995 | Issued |
Array
(
[id] => 1595230
[patent_doc_number] => 06492177
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Kit for use in treatment of polycystic ovarian disease'
[patent_app_type] => B1
[patent_app_number] => 08/436023
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2789
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492177.pdf
[firstpage_image] =>[orig_patent_app_number] => 08436023
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436023 | Kit for use in treatment of polycystic ovarian disease | May 4, 1995 | Issued |
Array
(
[id] => 3623034
[patent_doc_number] => 05688911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Trk neurotrophin binding motifs'
[patent_app_type] => 1
[patent_app_number] => 8/434198
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6087
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688911.pdf
[firstpage_image] =>[orig_patent_app_number] => 434198
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434198 | Trk neurotrophin binding motifs | May 2, 1995 | Issued |
Array
(
[id] => 3771045
[patent_doc_number] => 05756456
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Methods involving sensory and motor neuron derived factor (SMDF)'
[patent_app_type] => 1
[patent_app_number] => 8/428927
[patent_app_country] => US
[patent_app_date] => 1995-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 33696
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756456.pdf
[firstpage_image] =>[orig_patent_app_number] => 428927
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/428927 | Methods involving sensory and motor neuron derived factor (SMDF) | Apr 24, 1995 | Issued |
Array
(
[id] => 3868419
[patent_doc_number] => 05763213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Sensory and motor neuron derived factor (SMDF)'
[patent_app_type] => 1
[patent_app_number] => 8/428298
[patent_app_country] => US
[patent_app_date] => 1995-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 33683
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763213.pdf
[firstpage_image] =>[orig_patent_app_number] => 428298
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/428298 | Sensory and motor neuron derived factor (SMDF) | Apr 24, 1995 | Issued |
Array
(
[id] => 3805522
[patent_doc_number] => 05830858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Neurotrophic factor'
[patent_app_type] => 1
[patent_app_number] => 8/424826
[patent_app_country] => US
[patent_app_date] => 1995-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18703
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830858.pdf
[firstpage_image] =>[orig_patent_app_number] => 424826
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/424826 | Neurotrophic factor | Apr 18, 1995 | Issued |
| 08/426419 | NOVEL NEUROTHROPHIC FACTOR | Apr 18, 1995 | Abandoned |
Array
(
[id] => 3557013
[patent_doc_number] => 05543498
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-06
[patent_title] => 'Peptides to overcome inhibition of nerve growth'
[patent_app_type] => 1
[patent_app_number] => 8/417279
[patent_app_country] => US
[patent_app_date] => 1995-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 5619
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/543/05543498.pdf
[firstpage_image] =>[orig_patent_app_number] => 417279
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/417279 | Peptides to overcome inhibition of nerve growth | Apr 4, 1995 | Issued |
Array
(
[id] => 3627437
[patent_doc_number] => 05621079
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Neuropeptide Y receptor'
[patent_app_type] => 1
[patent_app_number] => 8/415818
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 13397
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621079.pdf
[firstpage_image] =>[orig_patent_app_number] => 415818
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415818 | Neuropeptide Y receptor | Apr 2, 1995 | Issued |
Array
(
[id] => 1173221
[patent_doc_number] => 06750196
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-15
[patent_title] => 'Methods of treating disorders of the eye'
[patent_app_type] => B1
[patent_app_number] => 08/411295
[patent_app_country] => US
[patent_app_date] => 1995-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 56
[patent_no_of_words] => 15427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750196.pdf
[firstpage_image] =>[orig_patent_app_number] => 08411295
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/411295 | Methods of treating disorders of the eye | Mar 26, 1995 | Issued |
| 08/408094 | LIGAND-MEDIATED IMMUNOFUNCTIONAL HORMONE BINDING PROTEIN ASSAY METHOD | Mar 20, 1995 | Abandoned |
Array
(
[id] => 3625510
[patent_doc_number] => 05608036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-04
[patent_title] => 'Enhanced secretion of polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/407344
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10335
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/608/05608036.pdf
[firstpage_image] =>[orig_patent_app_number] => 407344
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/407344 | Enhanced secretion of polypeptides | Mar 19, 1995 | Issued |
Array
(
[id] => 3948282
[patent_doc_number] => 05955354
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'RAS P21-interacting protein (RGL) and its RAS interacting domain (RID)'
[patent_app_type] => 1
[patent_app_number] => 8/408519
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 19484
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955354.pdf
[firstpage_image] =>[orig_patent_app_number] => 408519
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408519 | RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) | Mar 19, 1995 | Issued |
| 08/403803 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN | Mar 16, 1995 | Abandoned |
Array
(
[id] => 3953900
[patent_doc_number] => 05935811
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Neuron-restrictive silencer factor nucleic acids'
[patent_app_type] => 1
[patent_app_number] => 8/398590
[patent_app_country] => US
[patent_app_date] => 1995-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 15996
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935811.pdf
[firstpage_image] =>[orig_patent_app_number] => 398590
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/398590 | Neuron-restrictive silencer factor nucleic acids | Mar 2, 1995 | Issued |